Mitophagy in cells with mtDNA mutations: being sick is not enough

Autophagy
Rosa L A de VriesEric A Schon

Abstract

Despite the emergence of autophagy as a key process for mitochondrial quality control, the existence and persistence of pathogenic mtDNA mutations in human disease suggests that the degradation of dysfunctional mitochondria does not occur widely in vivo. During macroautophagy, a double-membraned cup-shaped structure engulfs cytosolic content. This autophagic vesicle then fuses with lysosomes, allowing hydrolytic enzymes to degrade the contents. Mitochondrial autophagy, or mitophagy, is thought to degrade damaged or nonfunctioning mitochondria specifically. The Parkinson disease-related proteins PINK1 (a mitochondrially localized kinase) and PARK2 (PARKIN, a cytosolically-localized E3 ubiquitin ligase) are essential for targeting mitochondria for mitophagy. Upon chemical uncoupling of the mitochondrial transmembrane potential (Δψ(m)), PINK1 located in the mitochondrial outer membrane recruits PARK2 from the cytosol to the mitochondria, followed by delivery of the organelle to the autophagic machinery for degradation.

Citations

Jun 30, 2012·Cell Death and Differentiation·G Ashrafi, T L Schwarz
Oct 9, 2013·Human Molecular Genetics·Ying DaiDavid K Simon
May 28, 2014·Philosophical Transactions of the Royal Society of London. Series B, Biological Sciences·Karin B BuschJohannes N Spelbrink
May 28, 2014·Philosophical Transactions of the Royal Society of London. Series B, Biological Sciences·Ian J HoltThomas B L Kirkwood
Dec 26, 2015·American Journal of Epidemiology·Judita KnezTatiana Kuznetsova
May 17, 2014·Molecular Neurobiology·Abhishek Kumar MishraMahendra Pratap Singh
Jun 20, 2016·Environmental Toxicology and Pharmacology·Zhidan NiuYingmei Zhang
Dec 18, 2018·The Journal of Physiology·Michael D TarpeyEspen E Spangenburg
Jan 9, 2020·American Journal of Physiology. Cell Physiology·Maria A MitryJohn G Edwards
Aug 23, 2019·Annual Review of Nutrition·Xuan YangZhenglong Gu

❮ Previous
Next ❯

Related Concepts

Related Feeds

Parkinson's Disease & Autophagy (MDS)

Autophagy leads to degradation of damaged proteins and organelles by the lysosome. Impaired autophagy has been implicated in several diseases. Here is the role of autophagy in Parkinson’s disease.

Parkinson's Disease & Autophagy

Autophagy leads to degradation of damaged proteins and organelles by the lysosome. Impaired autophagy has been implicated in several diseases. Here is the role of autophagy in Parkinson’s disease.

Autophagy & Model Organisms

Autophagy is a cellular process that allows degradation by the lysosome of cytoplasmic components such as proteins or organelles. Here is the latest research on autophagy & model organisms

Autophagy Networks

Autophagy is a lysosomal pathway that involves degradation of proteins and functions in normal growth and pathological conditions, through a series of complex networks. The catabolic process involves delivery of proteins and organelles to the lysosome. Here is the latest research on autophagy networks.

Autophagy & Aging: Inhibitors

The feed focuses on the role of nuclear export inhibitors and their effect on autophagy and the aging process.